Cargando...
Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
The erythropoietin receptor (EpoR) was discovered and described in red blood cells (RBCs), stimulating its proliferation and survival. The target in humans for EpoR agonists drugs appears clear—to treat anemia. However, there is evidence of the pleitropic actions of erythropoietin (Epo). For that re...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
ScholarOne
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3646093/ https://ncbi.nlm.nih.gov/pubmed/23615965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2013.00025 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|